About US
Contact us
-
Italian antitrust agency probes alleged Roche-Novartis cartelItalian antitrust watchdogs have entered the Avastin-vs.-Lucentis fray. The Italian Competition Authority opened an investigation of Roche ($RHHBY) and Novartis ($NVS) on suspicion of a "cartel" des2013/2/20
-
GSK, Roche teaming with anti-doping agencyDrugmakers have watched their products become performance-enhancing tools for athletes for years. Steroids, human grown hormone and the now-notorious EPO, among others, came out of Big Pharma's labs2013/2/20
-
Novartis nabs another FDA-approved indication for everolimusTurns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everoli2013/2/19
-
Pfizer shutters CovX research operation in San DiegoPfizer ($PFE) is closing its CovX R&D operation in San Diego a little more than four years after buying the biotech company. About 100 jobs will be lost in the shudown2013/2/19
-
Takeda preps for first Actos trial now opening in L.A.The first trial of a lawsuit linking the diabetes drug Actos with bladder cancer is about to begin. As Bloomberg reports, jury selection starts today in Los Angeles, as Takeda Pharmaceuticals gears2013/2/19
-
UPDATED: Novartis nixes $78M non-compete with VasellaThe news of Daniel Vasella's $78 million payoff from Novartis couldn't have surfaced at a worse time. Once again, the Swiss drugmaker ($NVS) became a lightning rod for executive-pay watchdogs. And t2013/2/18
-
SFDA issues Technical Requirements for the Study of New Natural MedicinesTo improve the legal system for registration, standardize the registration of traditional Chinese medicines and natural medicines and encourage innovation, the State Food and Drug Administration (SFDA2013/2/17
-
SFDA Commissioner Yin Li meets the Ambassador of Switzerland to ChinaOn the afternoon of February 4, 2013, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Jacques de Watteville, the Ambassador of Switzerland to China, an2013/2/17
-
Merck loses 'bellwether' Fosamax caseYou win some and you lose some and this time, Merck ($MRK) lost to the tune of $285,000 when a jury said it was not up front about the risks of osteoporosis drugFosamax. And the sting of this loss was2013/2/7
-
GSK to hack jobs in Europe where austerity has taken tollEuropean austerity is taking on a very personal meaning at GlaxoSmithKline ($GSK).CEO Sir Andrew Wittysays more cost-cutting is coming, and the brunt of it will fall on workers and operations in Europ2013/2/7